THE PROBLEM
The United States’ medicine supply chain is broken, becoming dangerously dependent upon Foreign Suppliers for our most essential medicines.
More than 80% of active pharmaceutical ingredients are produced overseas
The manufacturing of medicine in the US is vulnerable to disruptions in foreign medicine supply chains—this has been made more pressing by recent trade wars and the COVID-19 pandemic.
OUR SOLUTION
A public benefit corporation dedicated to manufacturing and securing our nation’s most essential medicines, 100% in the U.S.
BOARD OF DIRECTORS

Eric Edwards, MD PhD.
Eric Edwards, MD PhD.
Co-Founder & CEO

Dr. Frank Gupton, PhD.
Dr. Frank Gupton, PhD.
Co-Founder, Phlow and CEO, Medicines for All

Martin Van Trieste
Martin Van Trieste
President & CEO, Civica Rx

Marshall L. Summar, MD
Marshall L. Summar, MD
Strategic Advisor and Member of the Board

Rosemary Gibson
Rosemary Gibson
Strategic Advisor and Member of the Board

Thomas O’Malley
Thomas O’Malley
Strategic Advisor and Member of the Board